Senzar Asset Management’s Insmed INSM Stock Holding History

Senzar Asset Management’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-238,700	Closed	-$7.45M	–	33
2017 Q3	$7.45M	Buy	+238,700	New	+$4.55M	1.82%	17
2016 Q4	–	Sell	-593,336	Closed	-$8.62M	–	33
2016 Q3	$8.62M	Sell	593,336 -195,600	-25%	-$2.45M	2.23%	18
2016 Q2	$7.78M	Sell	788,936 -316,062	-29%	-$3.69M	1.69%	20
2016 Q1	$14M	Buy	1,104,998 +415,891	+60%	+$5.47M	2.78%	12
2015 Q4	$12.5M	Buy	689,107 +113,700	+20%	+$2M	1.39%	20
2015 Q3	$10.7M	Buy	575,407 +111,100	+24%	+$2.77M	1.55%	17
2015 Q2	$11.3M	Sell	464,307 -74,800	-14%	-$1.7M	1.95%	20
2015 Q1	$11.2M	Sell	539,107 -138,493	-20%	-$2.44M	2.73%	14
2014 Q4	$10.5M	Buy	677,600 +14,300	+2%	+$203K	3.07%	13
2014 Q3	$8.66M	Sell	663,300 -155,400	-19%	-$2.34M	2.54%	15
2014 Q2	$16.4M	Buy	+818,700	New	+$12.1M	6.25%	5

Other funds holding INSM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Senzar Asset Management's INSM Position: Q4 2017 in Review

Senzar Asset Management sold out of Insmed (INSM) in Q4 2017, closing a stake of 238,700 shares — an estimated $7.45M sold.

Senzar Asset Management first reported a position in INSM in Q2 2014 and held it in 11 quarters. The position peaked at $16.4M in Q2 2014. 129 funds tracked by Wall St. Rank hold INSM as of Q4 2017.

Senzar Asset Management reported no remaining Insmed position as of Q4 2017 after selling out during the quarter.
Senzar Asset Management sold 238,700 Insmed shares in Q4 2017, an estimated $7.45M.
Senzar Asset Management first reported a position in Insmed in Q2 2014 and held it in 11 quarters.
Senzar Asset Management's Insmed position peaked at $16.4M in Q2 2014.
129 funds tracked by Wall St. Rank held Insmed as of Q4 2017.

Based on Senzar Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.